Panchsheel Organics Ltd

Panchsheel Organics Ltd is rated Sell by MarketsMOJO, with this rating last updated on 06 Jan 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 06 April 2026, providing investors with an up-to-date view of the company’s performance and outlook.

A sharp decline in Panchsheel Organics Ltd has pushed the stock to a fresh 52-week low of Rs 89.35 on 30 Mar 2026, marking a significant 12.52% drop over the past two sessions amid heightened volatility and sector underperformance.

Panchsheel Organics Ltd is rated Sell by MarketsMOJO, with this rating last updated on 06 Jan 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 26 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

A sustained decline has pushed Panchsheel Organics Ltd to a fresh 52-week low of Rs 92 on 24 Mar 2026, marking a significant -37.49% drop over the past year and underscoring persistent headwinds for the micro-cap pharmaceutical player.

For the fifth consecutive session, Panchsheel Organics Ltd closed lower, breaching its 52-week low at Rs 92.25 on 23 Mar 2026, marking a sharp decline of 9.56% intraday and underperforming its sector by 3.58%.

Panchsheel Organics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.97 today, marking a significant decline amid broader market movements. The stock has underperformed its sector and benchmark indices, reflecting ongoing pressures on its valuation and performance metrics.

Panchsheel Organics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, touched a new 52-week low of Rs.98.25 today, marking a significant decline amid broader market weakness and persistent underperformance relative to benchmarks.

Panchsheel Organics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 Jan 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 March 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Panchsheel Organics Ltd’s share price declined to a fresh 52-week low of Rs.99.1 on 9 Mar 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical and biotechnology company’s shares have underperformed both their sector and broader market benchmarks, reflecting persistent challenges in financial performance and market sentiment.

Panchsheel Organics Ltd, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.100 today, marking a significant milestone in its ongoing price decline. The stock has underperformed its sector and benchmark indices, reflecting persistent challenges in its market performance and financial metrics.

Panchsheel Organics Ltd is rated Sell by MarketsMOJO, with this rating last updated on 06 Jan 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 March 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Panchsheel Organics Ltd is rated Sell by MarketsMOJO, with this rating last updated on 06 Jan 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 February 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Panchsheel Organics Ltd., the Indore-based pharmaceutical manufacturer specialising in Active Pharma Ingredients and finished formulations, reported a net profit of ₹3.68 crores for Q3 FY26 (Oct-Dec'25), marking a sequential improvement of 41.00% from Q2 FY26's ₹2.61 crores. Despite this quarterly recovery, the ₹158.06 crore market capitalisation company continues to grapple with structural margin pressures that have persisted across recent quarters, raising questions about the sustainability of profitability amidst tepid revenue growth.

Panchsheel Organics Ltd, a player in the Pharmaceuticals & Biotechnology sector, has reported a flat financial performance for the quarter ended December 2025, signalling a stabilisation after a period of decline. Despite posting its highest quarterly profit after tax (PAT) and earnings per share (EPS) in recent history, the company continues to face challenges with its return on capital employed (ROCE), which remains at a multi-quarter low. This mixed financial trend has prompted a downgrade in the company’s Mojo Grade from Hold to Sell as of 6 January 2025.

Panchsheel Organics Ltd is rated Sell by MarketsMOJO, with this rating last updated on 06 January 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 08 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Panchsheel Organics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 Jan 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 January 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trend, and technical outlook.